 | • レポートコード：QFJ1-6062 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、鎌状赤血球症治療薬に伴う血管閉塞危機の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SGD-2083、クリザンリズマブ、PF-04447943、NVX-508、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・鎌状赤血球症治療薬に伴う血管閉塞危機の市場動向 ・企業の競争状況、市場シェア ・鎌状赤血球症治療薬に伴う血管閉塞危機の種類別市場規模と予測2016-2027（SGD-2083、クリザンリズマブ、PF-04447943、NVX-508、その他） ・鎌状赤血球症治療薬に伴う血管閉塞危機の用途別市場規模と予測2016-2027（クリニック、病院、その他） ・鎌状赤血球症治療薬に伴う血管閉塞危機の北米市場規模2016-2027（アメリカ、カナダ） ・鎌状赤血球症治療薬に伴う血管閉塞危機の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・鎌状赤血球症治療薬に伴う血管閉塞危機のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・鎌状赤血球症治療薬に伴う血管閉塞危機の中南米市場規模2016-2027（メキシコ、ブラジル） ・鎌状赤血球症治療薬に伴う血管閉塞危機の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca Plc、Bristol-Myers Squibb Company、Gilead Sciences Inc、Modus Therapeutics Holding AB、Novartis AG、NuvOx Pharma LLC、Pfizer Inc、Seattle Genetics Inc） ・結論 |
Market Analysis and Insights: Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market
The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market.
Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Scope and Market Size
Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
SGD-2083
Crizanlizumab
PF-04447943
NVX-508
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca Plc
Bristol-Myers Squibb Company
Gilead Sciences Inc
Modus Therapeutics Holding AB
Novartis AG
NuvOx Pharma LLC
Pfizer Inc
Seattle Genetics Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 SGD-2083
1.2.3 Crizanlizumab
1.2.4 PF-04447943
1.2.5 NVX-508
1.2.6 Others
1.3 Market by Application
1.3.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Perspective (2016-2027)
2.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Growth Trends by Regions
2.2.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Historic Market Share by Regions (2016-2021)
2.2.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Regions (2022-2027)
2.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Dynamic
2.3.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Trends
2.3.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Drivers
2.3.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Challenges
2.3.4 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players by Revenue
3.1.1 Global Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players by Revenue (2016-2021)
3.1.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Players (2016-2021)
3.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue
3.4 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Concentration Ratio
3.4.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in 2020
3.5 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Key Players Head office and Area Served
3.6 Key Players Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Solution and Service
3.7 Date of Enter into Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Breakdown Data by Type
4.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Historic Market Size by Type (2016-2021)
4.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Type (2022-2027)
5 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Breakdown Data by Application
5.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Historic Market Size by Application (2016-2021)
5.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2016-2027)
6.2 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
6.2.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021)
6.2.2 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027)
6.2.3 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2027)
6.3 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
6.3.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021)
6.3.2 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027)
6.3.3 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2027)
6.4 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country
6.4.1 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021)
6.4.2 North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2016-2027)
7.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
7.2.1 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021)
7.2.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027)
7.2.3 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2027)
7.3 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
7.3.1 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021)
7.3.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027)
7.3.3 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2027)
7.4 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country
7.4.1 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021)
7.4.2 Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2016-2027)
8.2 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
8.2.1 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
8.3.1 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region
8.4.1 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2016-2027)
9.2 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
9.2.1 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021)
9.2.2 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027)
9.2.3 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2027)
9.3 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
9.3.1 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021)
9.3.2 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027)
9.3.3 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2027)
9.4 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country
9.4.1 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021)
9.4.2 Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (2016-2027)
10.2 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type
10.2.1 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application
10.3.1 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country
10.4.1 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.1.4 AstraZeneca Plc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.1.5 AstraZeneca Plc Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Gilead Sciences Inc
11.3.1 Gilead Sciences Inc Company Details
11.3.2 Gilead Sciences Inc Business Overview
11.3.3 Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.3.4 Gilead Sciences Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.3.5 Gilead Sciences Inc Recent Development
11.4 Modus Therapeutics Holding AB
11.4.1 Modus Therapeutics Holding AB Company Details
11.4.2 Modus Therapeutics Holding AB Business Overview
11.4.3 Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.4.4 Modus Therapeutics Holding AB Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.4.5 Modus Therapeutics Holding AB Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.5.4 Novartis AG Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 NuvOx Pharma LLC
11.6.1 NuvOx Pharma LLC Company Details
11.6.2 NuvOx Pharma LLC Business Overview
11.6.3 NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.6.4 NuvOx Pharma LLC Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.6.5 NuvOx Pharma LLC Recent Development
11.7 Pfizer Inc
11.7.1 Pfizer Inc Company Details
11.7.2 Pfizer Inc Business Overview
11.7.3 Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.7.4 Pfizer Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.7.5 Pfizer Inc Recent Development
11.8 Seattle Genetics Inc
11.8.1 Seattle Genetics Inc Company Details
11.8.2 Seattle Genetics Inc Business Overview
11.8.3 Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Introduction
11.8.4 Seattle Genetics Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
11.8.5 Seattle Genetics Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of SGD-2083
Table 3. Key Players of Crizanlizumab
Table 4. Key Players of PF-04447943
Table 5. Key Players of NVX-508
Table 6. Key Players of Others
Table 7. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Regions (2016-2021)
Table 11. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Regions (2022-2027)
Table 13. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Trends
Table 14. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Drivers
Table 15. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Challenges
Table 16. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Restraints
Table 17. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Players (2016-2021)
Table 19. Global Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug as of 2020)
Table 20. Ranking of Global Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Solution and Service
Table 24. Date of Enter into Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Type (2016-2021)
Table 28. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Application (2016-2021)
Table 32. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 64. AstraZeneca Plc Company Details
Table 65. AstraZeneca Plc Business Overview
Table 66. AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 67. AstraZeneca Plc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021) & (US$ Million)
Table 68. AstraZeneca Plc Recent Development
Table 69. Bristol-Myers Squibb Company Company Details
Table 70. Bristol-Myers Squibb Company Business Overview
Table 71. Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 72. Bristol-Myers Squibb Company Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021) & (US$ Million)
Table 73. Bristol-Myers Squibb Company Recent Development
Table 74. Gilead Sciences Inc Company Details
Table 75. Gilead Sciences Inc Business Overview
Table 76. Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 77. Gilead Sciences Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021) & (US$ Million)
Table 78. Gilead Sciences Inc Recent Development
Table 79. Modus Therapeutics Holding AB Company Details
Table 80. Modus Therapeutics Holding AB Business Overview
Table 81. Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 82. Modus Therapeutics Holding AB Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021) & (US$ Million)
Table 83. Modus Therapeutics Holding AB Recent Development
Table 84. Novartis AG Company Details
Table 85. Novartis AG Business Overview
Table 86. Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 87. Novartis AG Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021) & (US$ Million)
Table 88. Novartis AG Recent Development
Table 89. NuvOx Pharma LLC Company Details
Table 90. NuvOx Pharma LLC Business Overview
Table 91. NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 92. NuvOx Pharma LLC Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021) & (US$ Million)
Table 93. NuvOx Pharma LLC Recent Development
Table 94. Pfizer Inc Company Details
Table 95. Pfizer Inc Business Overview
Table 96. Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 97. Pfizer Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021) & (US$ Million)
Table 98. Pfizer Inc Recent Development
Table 99. Seattle Genetics Inc Company Details
Table 100. Seattle Genetics Inc Business Overview
Table 101. Seattle Genetics Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021) & (US$ Million)
Table 102. Seattle Genetics Inc Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Type: 2020 VS 2027
Figure 2. SGD-2083 Features
Figure 3. Crizanlizumab Features
Figure 4. PF-04447943 Features
Figure 5. NVX-508 Features
Figure 6. Others Features
Figure 7. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Report Years Considered
Figure 12. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Regions: 2020 VS 2027
Figure 15. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Regions (2022-2027)
Figure 16. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Players in 2020
Figure 17. Global Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in 2020
Figure 19. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Type (2016-2021)
Figure 20. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Type (2022-2027)
Figure 21. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Type (2016-2027)
Figure 23. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Application (2016-2027)
Figure 24. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2016-2027)
Figure 25. United States Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Type (2016-2027)
Figure 29. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Application (2016-2027)
Figure 30. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2016-2027)
Figure 31. Germany Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Region (2016-2027)
Figure 41. China Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Type (2016-2027)
Figure 49. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Application (2016-2027)
Figure 50. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2016-2027)
Figure 51. Mexico Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2016-2027)
Figure 57. Turkey Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AstraZeneca Plc Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
Figure 61. Bristol-Myers Squibb Company Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
Figure 62. Gilead Sciences Inc Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
Figure 63. Modus Therapeutics Holding AB Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
Figure 64. Novartis AG Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
Figure 65. NuvOx Pharma LLC Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
Figure 66. Pfizer Inc Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
Figure 67. Seattle Genetics Inc Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の鎌状赤血球症診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sickle Cell Disease Diagnosis Market The global Sickle Cell Disease Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…- 鎌状赤血球症薬のグローバル市場調査 2019年 The global Sickle Cell Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Sickle Cell Disease Drug volume and value at global level, regional level and company level. From a global perspec…
- 鎌状赤血球症薬のグローバル市場調査 2019年 The global Sickle Cell Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Sickle Cell Disease Drug volume and value at global level, regional level and company level. From a global perspec…
- 世界の鎌状赤血球貧血検査＆スクリーニング市場規模・現状・予測（2021年-2027年） Sickle Cell Disease, an inherited blood disorder, often causes red blood cells (RBCs) to become sickle-shaped through the presence of the abnormal hemoglobin S variant. Highly rigid sickle-shaped blood may have difficulty passing through small blood vessels, blocking the normal blood flow, damaging …
- 世界のメニエール病治療薬パイプライン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Meniere Disease Drug Pipeline Market The global Meniere Disease Drug Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…